AI assistant
Sending…
Arcadia Biosciences, Inc. — Director's Dealing 2017
Nov 21, 2017
35424_dirs_2017-11-21_752a71f7-0a64-4477-8396-a208f8b567c0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2017-11-17
Reporting Person: Lu Zhongjin (VP Product Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-17 | Common Stock | S | 5950 | $0.228 | Disposed | 11153 | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $0.225 to $0.233. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
More from Arcadia Biosciences, Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Feb 6
Regulatory Filings
2026
Jan 28
Regulatory Filings
2026
Jan 14
Regulatory Filings
2025
Dec 29
Regulatory Filings
2025
Dec 29
Regulatory Filings
2025
Dec 23
Annual Report
2025
Nov 19